Furthermore, elisidepsin was more effective in the induction of ErbB3 dephosphorylation and degradation than that of ErbB2 (HER2) and ErbB1 (EGFR) in human NSCLC cell lines. This evidence concerns the gene EGFR and non-small cell lung carcinoma.